Terez, Margie V.
HRN: 09-06-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
CEFTRIAXONE 1G (VIAL)
05/17/2022
05/24/2022
IV
2grams
OD
UA Pus Cells 15-29
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes